A Study on the Application of Aromatherapy Combined With Transcranial Magnetic Stimulation in Insomnia of Stroke Patients

Exploring the application efficacy of aromatherapy combined with transcranial magnetic stimulation on insomnia in patients with cerebral stroke

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Stroke Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Nervous System Diseases Vascular Diseases

Age range

24 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Clinical diagnosis of stroke
Insomnia patients
Sign the informed consent form, cooperate voluntarily
Accord with the diagnosis of "insomnia" in traditional Chinese medicine
Evaluation has no taboo on transcranial magnetism
The age range is between 24 and 65

Exclusion criteria

Disturbance of consciousness
Cognitive impairment
Mental abnormality
Sleep apnea syndrome
Restless leg syndrome

Treatment and study plan

Aromatherapy

Behavioral

1.Aromatherapy is made from self-made sachet of traditional Chinese medicine.Its components (albizzia, Angelica dahurica, cardamom, Polygala, Evodia, Magnolia, Acorus calamus) are 10g each. Place the pillow 1 hour in advance. It is forbidden to play with your mobile phone or turn off the lights before going to bed.

Primary outcomes

Respiratory sleep monitoring

Time frame: From enrollment to the end of treatment for 3 weeks

The average length of sleep in a week Sleep breathing monitoring was determined by evaluation before and after treatment. The main purpose of this study was to observe whether the average sleep time of patients increased significantly after treatment.

Secondary outcomes

Pittsburgh sleep quality index,PSQI

Time frame: From enrollment to the end of treatment for 3 weeks

Pittsburgh sleep quality index（PSQI） The Pittsburgh Sleep quality Index (PSQI) was used to evaluate the sleep status of the patients before treatment and after three weeks of treatment. The total score of the scale was 0-21. The higher the score, the worse the sleep quality.

Sponsors and collaborators

Lead sponsor

Dandan Wu

Other

Registry information

Important dates

Study start: 2025
Primary completion: 2026
Study completion: 2026
First posted: Oct 2, 2025
Registry last updated: Oct 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting